Xyzal has the strangest family tree on the allergy shelf. Cetirizine, the molecule in Zyrtec, is actually two mirror-image versions of itself packaged together, and only one of them does most of the antihistamine work. Xyzal (levocetirizine) is that working half, isolated and sold on its own. The result is a pill with Zyrtec-class strength at half the milligrams, and with the same two family secrets: it can make you sleepy, and long-term daily users sometimes discover an unpleasant surprise when they stop.

The side effects, in order of likelihood

The trial data is refreshingly clear. The most common side effect of Xyzal is drowsiness, reported by roughly 6 percent of adult users, versus around 2 percent on placebo. Behind it: fatigue, dry mouth, and in children, sore throat and cold-like symptoms. That drowsiness number is lower than cetirizine's roughly one in ten but far from zero, which is why the brand leaned into it and markets Xyzal as the nighttime allergy pill. Taken at bedtime, the timing turns the main side effect into a feature: peak sleepiness lands while you are asleep, and coverage carries through the next day.

The rebound itch: the side effect that arrives after you quit

The one that catches people off guard: stopping cetirizine or levocetirizine after months or years of daily use can trigger intense, body-wide itching within a day or two of the last dose. The FDA added a warning about this in 2019 after accumulating case reports. It is not the allergy roaring back; it is the skin recalibrating after long histamine suppression, and restarting the pill relieves it within hours, which is exactly how people get stuck in a loop. The usual escape is a slow taper rather than a cold stop, ideally with a clinician involved. If you have been on Xyzal daily for years, this belongs in your decision about whether to continue.

The modern allergy toolkit: pills that block symptoms daily, and immunotherapy that retrains the response. Xyzal lives firmly in the first category.

Xyzal vs. Allegra: the matchup that decides most purchases

These two are the poles of the second-generation shelf. Xyzal is the potency pick: in skin-test studies levocetirizine suppresses allergic wheals more strongly, and many patients with stubborn symptoms feel the difference. Allegra (fexofenadine) is the clarity pick: its drowsiness rate is essentially placebo, it is the only antihistamine the FAA clears for pilots, and its main quirk is that fruit juice blocks its absorption. The honest trade: choose Xyzal when symptoms are winning and you can dose at night; choose Allegra when a foggy head costs you more than a lingering sniffle. Neither is "better"; they are tuned differently.

Claritin vs. Xyzal: gentle versus strong

Claritin (loratadine) is the mildest of the big three in both directions: less sedating than Xyzal, and for many people, noticeably less powerful. It is also slower, taking one to three hours to reach full effect versus under an hour for levocetirizine. A sensible pattern we see in clinic: Claritin for the light-pollen shoulder seasons, Xyzal at night during the weeks the count goes vertical. If Claritin has simply stopped keeping up, that is less a drug failure than a signal about your allergic load.

Who should be careful with Xyzal

Xyzal is what happened when chemists kept the strength of cetirizine and shaved off some of the fog. It is a good pill. It is still a pill you will take every day for as long as the allergy runs the show.
Dr. Chet Tharpe, Board Certified Allergist / Immunologist

The bigger question behind the nightly pill

Every antihistamine on this shelf, Xyzal included, manages the symptom side of a signal your immune system should not be sending. If the nightly pill has become a permanent fixture, the alternative worth knowing about is sublingual immunotherapy: daily under-the-tongue drops that expose the immune system to tiny amounts of what triggers it until it stops overreacting. It treats the cause rather than muting the alarm, and it is the difference between renting relief and owning it. Start with how allergy drops work, then the honest numbers in our cost guide. And if your issue is specifically the fog, the full story of antihistamine drowsiness is in the Zyrtec guide.

SLEEP ON IT, LITERALLY

Needing Xyzal every night to feel normal?

A free 60-second assessment maps your triggers and whether retraining your immune system could end the nightly pill routine.

Join Thousands Finding Relief

Frequently Asked Questions

What are the most common side effects of Xyzal?

Drowsiness leads at roughly 6 percent of adult users, followed by fatigue and dry mouth; children also report sore throat and cold-like symptoms. Serious reactions are rare. The drowsiness rate sits between Allegra, which is near placebo, and regular cetirizine, which affects about one user in ten.

Does Xyzal make you drowsy?

It can. About 6 percent of adults report somnolence in trials, which is why Xyzal is marketed for nighttime dosing: taken at bedtime, peak sleepiness lands during sleep while allergy coverage continues the next day. Avoid combining it with alcohol or other sedatives, and learn your response before driving.

Is Xyzal stronger than Zyrtec?

Xyzal is the active half of the cetirizine molecule, so 5 mg of levocetirizine delivers comparable antihistamine effect to 10 mg of cetirizine. Head-to-head, most patients notice no meaningful difference in strength; some report slightly less drowsiness on Xyzal. It is refinement, not escalation.

Which is better, Xyzal or Allegra?

Xyzal typically wins on raw potency in skin-test studies; Allegra wins decisively on drowsiness, with rates near placebo. Choose Xyzal for stubborn symptoms you can dose at bedtime, Allegra when daytime clarity matters most. Response varies by person, so a one-week trial of each is the practical tiebreaker.

Can stopping Xyzal cause itching?

Yes. Stopping cetirizine or levocetirizine after months of daily use can trigger intense whole-body itching within a day or two, a rebound effect the FDA formally warned about in 2019. Restarting relieves it, which traps people in a loop; a gradual taper with a clinician is the usual way out.